financetom
Business
financetom
/
Business
/
Meta Platforms Insider Sold Shares Worth $10,209,834, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Meta Platforms Insider Sold Shares Worth $10,209,834, According to a Recent SEC Filing
Jul 3, 2025 12:52 AM

03:43 AM EDT, 07/03/2025 (MT Newswires) -- Mark Zuckerberg, 10% Owner, Director, Chair of Board and Chief Executive Officer, on June 30, 2025, sold 13,793 shares in Meta Platforms ( META ) for $10,209,834. Following the Form 4 filing with the SEC, Zuckerberg has control over a total of 16,154 Class A common shares of the company, with 16,154 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1326801/000095010325008408/xslF345X05/dp231175_4-zuckerberg0630.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: NVIDIA-Backed Sakana AI Draws Strategic Investors in Japan
Market Chatter: NVIDIA-Backed Sakana AI Draws Strategic Investors in Japan
Sep 9, 2024
06:56 AM EDT, 09/09/2024 (MT Newswires) -- NVIDIA ( NVDA ) backed Sakana AI is attracting attention from strategic investors in Japan, Bloomberg reported on Monday. The report said that rising US-China tensions are leading to increased interest in the Tokyo-based startup, which recently secured over $100 million in funding, including from Nvidia ( NVDA ). Sakana AI's approach, using...
Relay Therapeutics' combo therapy for breast cancer cuts disease progression in early study
Relay Therapeutics' combo therapy for breast cancer cuts disease progression in early study
Sep 9, 2024
By Mariam Sunny and Sneha S K Sept 9 (Reuters) - Relay Therapeutics ( RLAY ) said on Monday interim data from an early-stage study of its experimental combination treatment for breast cancer showed it meaningfully extended the time patients lived without their disease worsening. The main goal of the trial, which enrolled 118 heavily pre-treated patients with PI3K mutant,...
Eli Lilly appoints insider Lucas Montarce as new finance chief
Eli Lilly appoints insider Lucas Montarce as new finance chief
Sep 9, 2024
Sept 9 (Reuters) - U.S. drugmaker Eli Lilly ( LLY ) on Monday said it has appointed insider Lucas Montarce as its new chief financial officer, effective immediately. Montarce, who joined Lilly in 2001, has held various finance leadership roles within the company, including head of finance for Lilly Research Laboratories. The appointment comes after former CFO Anat Ashkenazi stepped...
New Gold Up Near 1% in U.S. Premarket After Adding Sophie Bergeron and Ross Bhappu to Board
New Gold Up Near 1% in U.S. Premarket After Adding Sophie Bergeron and Ross Bhappu to Board
Sep 9, 2024
07:00 AM EDT, 09/09/2024 (MT Newswires) -- New Gold ( NGD ) was at last look up near 1% in U.S. premarket trade on Monday as it announced that Sophie Bergeron and Ross Bhappu have been appointed to its board of directors. A statement noted Bergeron is currently the Managing Director, Diamonds for Rio Tinto Iron and Titanium and Diamonds...
Copyright 2023-2026 - www.financetom.com All Rights Reserved